Comprehensive Characterization of Immune Cell Infiltration Characteristics and Drug Sensitivity Analysis in Inflammatory Breast Cancer Based on Bioinformatic Strategy.

[1]  S. Fiering,et al.  Proactive Immunotherapeutic Approaches against Inflammatory Breast Cancer May Improve Patient Outcomes , 2022, Cells.

[2]  S. Tian,et al.  Comprehensive analysis of PLKs expression and prognosis in breast cancer. , 2022, Cancer genetics.

[3]  A. Degnim,et al.  Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy , 2022, Annals of Surgical Oncology.

[4]  D. Ribatti,et al.  Controversial role of mast cells in breast cancer tumor progression and angiogenesis. , 2021, Clinical breast cancer.

[5]  A. Lucci,et al.  Current Surgical Management of Inflammatory Breast Cancer , 2021, Annals of Surgical Oncology.

[6]  Diane D. Liu,et al.  Inflammatory breast cancer appearance at presentation is associated with overall survival , 2021, Cancer medicine.

[7]  A. Lánczky,et al.  Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation , 2021, Journal of medical Internet research.

[8]  H. Linden,et al.  A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer. , 2021, Clinical breast cancer.

[9]  A. Rana,et al.  Progress for Immunotherapy in Inflammatory Breast Cancer and Emerging Barriers to Therapeutic Efficacy , 2021, Cancers.

[10]  P. Provero,et al.  Meta-Analysis of Microdissected Breast Tumors Reveals Genes Regulated in the Stroma but Hidden in Bulk Analysis , 2021, Cancers.

[11]  G. Hortobagyi,et al.  Inflammatory breast cancer: early recognition and diagnosis is critical. , 2021, American journal of obstetrics and gynecology.

[12]  Maoli Wang,et al.  CASP9 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Inflammatory Breast Cancer , 2021, International journal of analytical chemistry.

[13]  Zuoheng Wang,et al.  Regulation and characterization of tumor-infiltrating immune cells in breast cancer. , 2020, International immunopharmacology.

[14]  P. Spanheimer,et al.  The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer , 2020, Annals of Surgical Oncology.

[15]  N. Ueno,et al.  Targeting Signaling Pathways in Inflammatory Breast Cancer , 2020, Cancers.

[16]  J. Bellon,et al.  Characteristics associated with inflammatory breast cancer (IBC): An epidemiologic study from a dedicated IBC program , 2020, The breast journal.

[17]  V. Valero,et al.  Update on systemic treatment for newly diagnosed inflammatory breast cancer , 2020, Journal of advanced research.

[18]  Jason T. George,et al.  Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum , 2020, bioRxiv.

[19]  Hu Huang,et al.  Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses. , 2020, Genetic testing and molecular biomarkers.

[20]  S. Rogatto,et al.  Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives , 2020, Cells.

[21]  L. Bielory,et al.  Mast Cell Biology at Molecular Level: a Comprehensive Review , 2019, Clinical Reviews in Allergy & Immunology.

[22]  F. Redegeld,et al.  Role of Mast Cells in Shaping the Tumor Microenvironment , 2019, Clinical Reviews in Allergy & Immunology.

[23]  B. Baradaran,et al.  Mast cells: A double-edged sword in cancer. , 2019, Immunology letters.

[24]  R. Orecchia.  Radiation therapy for inflammatory breast cancer. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[25]  A. Palazzo,et al.  Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer , 2018, Clinical breast cancer.

[26]  W. Woodward,et al.  Inflammatory breast cancer biology: the tumour microenvironment is key , 2018, Nature Reviews Cancer.

[27]  I. Holen,et al.  The breast tumor microenvironment: role in cancer development, progression and response to therapy , 2018, Expert review of molecular diagnostics.

[28]  S. Loi,et al.  Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice. , 2017, Biochimica et biophysica acta. Reviews on cancer.

[29]  A. Degnim,et al.  Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes , 2017, Clinical breast cancer.

[30]  Lili Tang,et al.  The tumor microenvironment and inflammatory breast cancer , 2017, Journal of Cancer.

[31]  D. Ribatti,et al.  Mast cells in breast cancer angiogenesis. , 2017, Critical reviews in oncology/hematology.

[32]  F. Bertucci,et al.  The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations? , 2017, Expert review of anticancer therapy.

[33]  F. Chan,et al.  The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment , 2017, Virchows Archiv.

[34]  M. Disis,et al.  Clinical significance of tumor-infiltrating lymphocytes in breast cancer , 2016, Journal of Immunotherapy for Cancer.

[35]  V. Valero,et al.  Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction , 2016, PloS one.

[36]  J. D. de Wilt,et al.  Inflammatory breast cancer: an overview. , 2015, Critical reviews in oncology/hematology.

[37]  Yu Cao,et al.  Inflammatory breast cancer (IBC): clues for targeted therapies , 2013, Breast Cancer Research and Treatment.

[38]  Randa El-Zein,et al.  Genomic and expression analysis of microdissected inflammatory breast cancer , 2013, Breast Cancer Research and Treatment.

[39]  L. Livi,et al.  Management of inflammatory breast cancer: focus on radiotherapy with an evidence-based approach. , 2013, Cancer treatment reviews.

[40]  S. Sayed,et al.  Fine-Needle Aspiration in Suspected Inflammatory Breast Cancer: Case Series with Emphasis on Approach to Specimen Adequacy , 2011, Acta Cytologica.

[41]  Melissa Bondy,et al.  Inflammatory Breast Cancer: The Disease, the Biology, the Treatment , 2010, CA: a cancer journal for clinicians.

[42]  S. Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[43]  G. Hortobagyi,et al.  Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma , 1979, Journal of surgical oncology.